InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Conditions: Cancer Risk; Cancer Predisposition Syndrome; Hereditary Cancer Prediction; Childhood Cancer Survivors; Adult Cancer Survivors; IARC Carcinogens; Smoking History; Lung Cancer; Ductal/Lobular Carcinoma; Barrett Esophagus; Pancreatic Precursor Lesions; Colonic Dysplasia/Adenomata; Non-Alcoholic Fatty Liver Disease; Non Alcoholic Steatohepatitis; Cirrhosis; High Grade Prostatic Epithelial Neoplasia; High-grade Bladder Urothelial Dysplasia/Carcinoma in Situ; Adenomatous Hyperplasia; High-risk Oral Precancerous D iseases; Melanocytic Lesion, Adult; Hematologic Malignancy; Lung; Node; Serous Tubal Intraepithelial Carcinoma; Endometrial Intraepithelial Neoplasia; Cervical and Endocervical Carcinoma in Situ; Vulvar Intraepithelial Neoplasia; Nephrogenic Rests; Benign Bone Lesions With Risk of Malignant Degeneration; Giant Cell Tumor; Osteochondroma; Spitz Nevus Intervention: Other: Samples Sponsor: Dana-Farber Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Cirrhosis | Esophagus Cancer | Hematology | Osteochondroma | Research